Why BridgeBio Pharma Stock Is Shooting Higher – BridgeBio Pharma (NASDAQ:BBIO)
BridgeBio Pharma Inc BBIO shares are trading higher by 16.77% to $7.87 Thursday afternoon after the company initiated its CALIBRATE Phase 3 study of Encaleret. What Else? BridgeBio Pharma says…